Flagship Harbor Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Flagship Harbor Advisors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,477	Closed	-$2K	–	2062
2019 Q4	$2K	Sell	2,477 -12,414	-83%	-$9.53K	﹤0.01%	1773
2019 Q3	$8K	Hold	14,891	–	–	﹤0.01%	1369
2019 Q2	$7K	Hold	14,891	–	–	﹤0.01%	1427
2019 Q1	$6K	Hold	14,891	–	–	﹤0.01%	1473
2018 Q4	$7K	Hold	14,891	–	–	﹤0.01%	1377
2018 Q3	$8K	Hold	14,891	–	–	﹤0.01%	1561
2018 Q2	$7K	Hold	14,891	–	–	﹤0.01%	1560
2018 Q1	$6K	Hold	14,891	–	–	﹤0.01%	363
2017 Q4	$6K	Hold	14,891	–	–	﹤0.01%	369
2017 Q3	$5K	Hold	14,891	–	–	﹤0.01%	345
2017 Q2	$6K	Sell	14,891 -13,000	-47%	-$5.31K	﹤0.01%	343
2017 Q1	$12K	Hold	27,891	–	–	﹤0.01%	324
2016 Q4	$13K	Buy	+27,891	New	+$9.44K	0.01%	288

Flagship Harbor Advisors's GCVRZ Position: Q1 2020 in Review

Flagship Harbor Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 2,477 shares — an estimated $2K sold.

Flagship Harbor Advisors first reported a position in GCVRZ in Q4 2016 and held it in 13 quarters. The position peaked at $13K in Q4 2016. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

Flagship Harbor Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 2,477 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $2K.
Flagship Harbor Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2016 and held it in 13 quarters.
Flagship Harbor Advisors's Sanofi Contingent Value Rights position peaked at $13K in Q4 2016.
2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Flagship Harbor Advisors's 13F filing for Q1 2020, filed 12 May 2020.